Article
Extending differential gene expression testing to handle genome aneuploidy in cancer
2025-04-03
Abstract excerpt
Genome aneuploidy, characterized by copy number variations (CNVs), profoundly alters gene expression in cancer through direct gene dosage effects and indirect compensatory regulatory mechanisms. However, existing differential gene expression (DGE) testing methods do not differentiate between these mechanisms, conflating all expression changes, limiting biological interpretability and obscuring key genes involved i...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 375bea47-b0ad-50cd-9acc-a0a2f566ef1a
- DOI
- 10.1101/2025.03.29.646108
